Arboretum Ventures’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Arboretum Ventures’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,859,050	Closed	-$2.77M	–	3
2023 Q1	$2.77M	Hold	10,859,050	–	–	8.16%	3
2022 Q4	$12.8M	Hold	10,859,050	–	–	23.91%	2
2022 Q3	$22.2M	Hold	10,859,050	–	–	22.34%	2
2022 Q2	$16.7M	Hold	10,859,050	–	–	18.57%	2
2022 Q1	$54.8M	Hold	10,859,050	–	–	44.55%	2
2021 Q4	$67.3M	Buy	+10,859,050	New	+$96.9M	38.79%	2

Arboretum Ventures's PEAR Position: Q2 2023 in Review

Arboretum Ventures sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 10,859,050 shares — an estimated $2.77M sold.

Arboretum Ventures first reported a position in PEAR in Q4 2021 and held it in 6 quarters. The position peaked at $67.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Arboretum Ventures reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Arboretum Ventures sold 10,859,050 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $2.77M.
Arboretum Ventures first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Arboretum Ventures's Pear Therapeutics, Inc. Class A Common Stock position peaked at $67.3M in Q4 2021.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Arboretum Ventures's 13F filing for Q2 2023, filed 21 Jul 2023.